Adaptive Biotechnologies Corp (ADPT)
$24.92
$-0.27
(-1.07%)
As on 31-Aug-2026 16:00EDT
Market cap
$4,020 Mln
Revenue (TTM)
$308 Mln
P/E Ratio
--
P/B Ratio
29.5
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-0.4 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
-1
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$-0.4
-
Face value
--
-
Shares outstanding
159,595,842
7 Years Aggregate
CFO
$-544.39 Mln
EBITDA
$-889.64 Mln
Net Profit
$-861.06 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Adaptive Biotechnologies Corp (ADPT)
| -61.6 | 3.1 | -58.9 | -52.7 | -3.0 | -29.5 | -- |
|
BSE Sensex*
| -9.2 | -1.6 | 2.8 | -3.7 | 5.8 | 6.0 | 10.4 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
|---|---|---|---|---|---|---|
|
Adaptive Biotechnologies Corp (ADPT)
| 170.9 | 22.1 | -35.9 | -72.8 | -52.5 | 97.6 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Adaptive Biotechnologies Corp (ADPT)
|
24.9 | 4,020.2 | 308.1 | -63.9 | -10.4 | -35.3 | -- | 29.5 |
| 82.4 | 11,993.9 | 669.5 | -320.0 | -0.8 | -71.1 | -- | 26.9 | |
| 70.9 | 10,022.2 | 71.0 | -894.0 | -1,175.8 | -- | -- | 60.3 | |
| 54.6 | 13,491.7 | 2,435.9 | 860.6 | 31.0 | 43 | 17.4 | 7.4 | |
| 106.5 | 11,957.0 | 1,663.7 | 413.6 | 36.3 | 430 | 30.9 | 84.5 | |
| 359.4 | 10,402.8 | 440.5 | 241.5 | 33.4 | 18.7 | 44.1 | 7.8 | |
| 540.0 | 12,332.1 | 1,283.9 | -325.1 | -19.0 | -57.7 | -- | 24.0 | |
| 594.0 | 16,765.1 | 2,782.3 | 491.5 | 21.1 | 110.1 | 35.2 | 39.3 | |
| 350.3 | 9,625.4 | 0.0 | -339.1 | -- | -30.6 | -- | 7.6 | |
| 147.8 | 9,339.4 | 282.0 | 82.9 | -28.6 | 11.4 | 140.1 | 11.5 |
Shareholding Pattern
View DetailsAbout Adaptive Biotechnologies Corp (ADPT)
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunosequencing platform which combines a suite of proprietary chemistry,... computational biology, and machine learning to generate clinical immunomics data to decode the adaptive immune system. It provides clonoSEQ diagnostic test which detects and monitors the remaining number of cancer cells that are present in a patient's body during and after treatment, known as Minimal Residual Disease (MRD). The company offers products and services for life sciences research, clinical diagnostics, and drug discovery applications. The company was formerly known as Adaptive TCR Corporation and changed its name to Adaptive Biotechnologies Corporation in December 2011. Adaptive Biotechnologies Corporation was incorporated in 2009 and is headquartered in Seattle, Washington. Read more
-
Co-Founder, CEO & Chairman
Mr. Chad M. Robins M.B.A.
-
Co-Founder, CEO & Chairman
Mr. Chad M. Robins M.B.A.
-
Headquarters
Seattle, WA
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Adaptive Biotechnologies Corp (ADPT)
What is the current share price of Adaptive Biotechnologies Corp (ADPT) Today?
The share price of Adaptive Biotechnologies Corp (ADPT) is $24.92 (NASDAQ) as of 31-Aug-2026 16:00 EDT. Adaptive Biotechnologies Corp (ADPT) has given a return of -3.02% in the last 3 years.
What is the current PB & PE ratio of Adaptive Biotechnologies Corp (ADPT)?
Since, TTM earnings of Adaptive Biotechnologies Corp (ADPT) is negative, P/E ratio is not available.
The P/B ratio of Adaptive Biotechnologies Corp (ADPT) is 29.53 times as on 28-Aug-2026, a 470 premium to its peers’ median range of 5.18 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
-41.80 |
11.37 |
2024 |
-5.53 |
4.35 |
2023 |
-3.15 |
2.30 |
2022 |
-5.46 |
2.35 |
2021 |
-19.12 |
6.56 |
What is the 52 Week High and Low of Adaptive Biotechnologies Corp (ADPT)?
The 52-week high and low of Adaptive Biotechnologies Corp (ADPT) are Rs 91.20 and Rs 20.90 as of 01-Sep-2026.
What is the market cap of Adaptive Biotechnologies Corp (ADPT)?
Adaptive Biotechnologies Corp (ADPT) has a market capitalisation of $ 4,020 Mln as on 28-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Adaptive Biotechnologies Corp (ADPT)?
Before investing in Adaptive Biotechnologies Corp (ADPT), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.